Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators goal is to determine the efficacy and duration of analgesia with the addition of Clonidine, an alpha-2 agonist, to local anesthetic blockade using bupivacaine, of the great auricular nerve in children undergoing tympanomastoid surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
• Treatments: Bupivacaine; Clonidine

Criteria

Inclusion Criteria:

• age 1-18 years

• tympanomastoid surgery (cochlear implant, mastoidectomy, cholesteatoma surgery)

• ASA I, II

• informed consent and assent obtained

Exclusion Criteria:

• allergic to local anesthestic

• taking chronic aspirin or Ibuprofen therapy

• ASA IV

• history of clinically important renal, hepatic, respiratory, cardiac, or neurological conditions

• Patients who have cardiovascular surgery other than an atrial septal defect or a ventricular septal defect, or who have undergone complete corrective intracardiac repair of congenital heart disease.

• Informed consent not obtained

• Patients expected to receive dexamethasone or ondansetron intra-operative